Cutler Group’s Apollo Endosurgery, Inc. APEN Stock Holding History

Cutler Group’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,400	Closed	-$13K	–	4446
2023 Q1	$13K	Buy	1,400 +100	+8%	+$991	﹤0.01%	2185
2022 Q4	$12K	Buy	+1,300	New	+$9.69K	﹤0.01%	2607
2021 Q4	–	Sell	-500	Closed	-$4K	–	6412
2021 Q3	$4K	Hold	500	–	–	﹤0.01%	4724
2021 Q2	$4K	Buy	500 +200	+67%	+$1.37K	﹤0.01%	4683
2021 Q1	$1K	Buy	+300	New	+$1.48K	﹤0.01%	5466

Cutler Group's APEN Position: Q2 2023 in Review

Cutler Group sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 1,400 shares — an estimated $13K sold.

Cutler Group first reported a position in APEN in Q1 2021 and held it in 5 quarters. The position peaked at $13K in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Cutler Group reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Cutler Group sold 1,400 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $13K.
Cutler Group first reported a position in Apollo Endosurgery, Inc. in Q1 2021 and held it in 5 quarters.
Cutler Group's Apollo Endosurgery, Inc. position peaked at $13K in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.